BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2150599)

  • 1. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
    Schönthal A; Feramisco JR
    New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
    Schönthal A; Alberts AS; Frost JA; Feramisco JR
    New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals.
    Jamal S; Ziff E
    Nature; 1990 Mar; 344(6265):463-6. PubMed ID: 2157161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription activation by serum, PDGF, and TPA through the c-fos DSE: cell type specific requirements for induction.
    Siegfried Z; Ziff EB
    Oncogene; 1989 Jan; 4(1):3-11. PubMed ID: 2915902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
    Zhang Y; Feng XH; Derynck R
    Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of human c-fos expression by the retinoblastoma gene product.
    Robbins PD; Horowitz JM; Mulligan RC
    Nature; 1990 Aug; 346(6285):668-71. PubMed ID: 2117257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
    Lengye E; Singh B; Gum R; Nerlov C; Sabichi A; Birrer M; Boyd D
    Oncogene; 1995 Dec; 11(12):2639-48. PubMed ID: 8545121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-fos transcriptional activation by IL-2 in mouse CTL-L2 cells is mediated through two distinct signal transduction pathways converging on the same enhancer element.
    Trouche D; Robin P; Robillard O; Sassone-Corsi P; Harel-Bellan A
    J Immunol; 1991 Oct; 147(7):2398-403. PubMed ID: 1918970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
    Fujii M; Minamino T; Nomura M; Miyamoto KI; Tanaka J; Seiki M
    Oncogene; 1996 May; 12(10):2193-202. PubMed ID: 8668346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-Mos proto-oncogene product stimulates c-Jun transcriptional activity by a MAP kinase-dependent mechanism.
    Sever R; Turner R
    Biochem Biophys Res Commun; 1996 Nov; 228(2):259-66. PubMed ID: 8920903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mos-induced inhibition of glucocorticoid receptor function is mediated by Fos.
    Touray M; Ryan F; Saurer S; Martin F; Jaggi R
    Oncogene; 1991 Feb; 6(2):211-7. PubMed ID: 1847998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
    Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
    Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
    Angel P; Smeal T; Meek J; Karin M
    New Biol; 1989 Oct; 1(1):35-43. PubMed ID: 2518690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.